Disease: Autoimmune myocarditis
- A 71-year-old male with a life-threatening recurrence of hemolytic anemia, thrombocytopenia, and acute kidney injury after pembrolizumab therapy: a case report
- A Case of Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab: A Case Report
- A multidisciplinary approach of a patient with pheochromocytoma presenting as recurrent acute fulminant myocarditis: A rare case report and comprehensive review of literature
- A rare presentation of acute myocarditis as a manifestation of adult-onset Still's disease: a case report
- Activation of ETAR and ETBR in myocardial tissue characterizes heart failure induced by experimental autoimmune myocarditis
- Acute cardiovascular complications of immune-mediated systemic inflammatory diseases
- Acute myocarditis: an overview of pathogenesis, diagnosis and management
- Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome
- Advances in research on molecular markers in immune checkpoint inhibitor-associated myocarditis
- An 85-Year-Old Man with Fever, Dyspnea, and Dry Cough Diagnosed with Idiopathic Hypereosinophilic Syndrome, Successfully Treated with High-Dose Corticosteroids
- ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
- Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype
- Background and roles: myosin in autoimmune diseases
- Baicalein alleviates cardiomyocyte death in EAM mice by inhibiting the JAK-STAT1/4 signalling pathway
- Biomarkers in Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Updated Review of the Literature
- Cardiac arrest in seronegative idiopathic inflammatory myopathy: a case report
- Cardiovascular Complications in Lupus Patients in the Aseer Region, Saudi Arabia
- Cardiovascular Disease: Inflammatory and Infectious Heart Conditions
- Case report: Systemic lupus erythematosus combined with myocardial hypertrophy
- CD4(+)T(EM) cells drive the progression from acute myocarditis to dilated cardiomyopathy in CVB3-induced BALB/c mice
- CD4<sup>+</sup>T<sub>EM</sub> cells drive the progression from acute myocarditis to dilated cardiomyopathy in CVB3-induced BALB/c mice
- Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives
- Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective
- COVID-19 vaccination-related autoimmune hepatitis-a perspective
- DIAGNOSTIC VALUE OF LABORATORY MARKERS OF SYNTROPIC LESIONS OF THE CIRCULATORY SYSTEM ORGANS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- Editorial: Cardiovascular involvement in autoimmune diseases, volume II
- Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-kappaB-dependent cardiomyocyte pyroptosis
- Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-κB-dependent cardiomyocyte pyroptosis
- Empagliflozin attenuates inflammation levels in autoimmune myocarditis through the STAT3 pathway and macrophage phenotype transformation
- ET-1 receptor type B (ETBR) overexpression associated with ICAM-1 downregulation leads to inflammatory attenuation in experimental autoimmune myocarditis
- Exploring Cardiovascular Manifestations in Vasculitides: An In-Depth Review
- Extracorporeal membrane oxygenation (ECMO) during aplasia: A bridge towards myopericarditis recovery after autologous hematopoietic stem cell transplant for systemic sclerosis and recent Coronarovirus disease (COVID-19) vaccination
- Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease
- Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease
- First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial
- Fulminant myocarditis in a patient with a history of autoimmune hepatitis
- IFITM3 mediates inflammation induced myocardial injury through JAK2/STAT3 signaling pathway
- Imaging in Rheumatic Immune-related Adverse Events
- Immune checkpoint inhibitor myocarditis in thymic epithelial tumors: a case report and literature review
- Immune checkpoint inhibitors induced side effects of the peripheral nervous system
- Innate and adaptive immunity in acute myocarditis
- Investigation into Cardiac Myhc-alpha 334-352-Specific TCR Transgenic Mice Reveals a Role for Cytotoxic CD4 T Cells in the Development of Cardiac Autoimmunity
- Investigation into Cardiac Myhc-α 334-352-Specific TCR Transgenic Mice Reveals a Role for Cytotoxic CD4 T Cells in the Development of Cardiac Autoimmunity
- Ivabradine Alleviates Experimental Autoimmune Myocarditis-Mediated Myocardial Injury
- Ivermectin ameliorates acute myocarditis via the inhibition of importin-mediated nuclear translocation of NF-kappaB/p65
- Long COVID-19 Pathophysiology: What Do We Know So Far?
- Lupeol alleviates autoimmune myocarditis by suppressing macrophage pyroptosis and polarization via PPARalpha/LACC1/NF-kappaB signaling pathway
- Lupeol alleviates autoimmune myocarditis by suppressing macrophage pyroptosis and polarization via PPARα/LACC1/NF-κB signaling pathway
- Lupus-Induced Accelerated Heart Failure in a Young African American Female: Cardiovascular and Systemic Complications of Noncompliance to Maintenance Therapy and the Social Determinants of Cardiovascular Disease
- Lymphocytic Perimyocarditis Masquerading as Steroid-Dependent Recurrent Pericarditis
- Macrophage membrane-modified targeted phase-change nanoparticles for multimodal imaging of experimental autoimmune myocarditis
- MicroRNAs in Myocarditis-Review of the Preclinical In Vivo Trials
- Mitochondrial extracellular vesicles, autoimmunity and myocarditis
- Modulation of TLR4/NFkappaB Pathways in Autoimmune Myocarditis
- Molecular mimic between cardiovascular diseases and microorganism antigens
- Mortality associated with myocardial damage by troponin I in patients with COVID 19
- Myocarditis and Pericarditis
- Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
- Novel uses of complement inhibitors in myasthenia gravis-Two case reports
- Paradigm shift in myocarditis treatment
- PCSK9 inhibition ameliorates experimental autoimmune myocarditis by reducing Th17 cell differentiation through LDLR/STAT-3/ROR-gammat pathway
- PCSK9 inhibition ameliorates experimental autoimmune myocarditis by reducing Th17 cell differentiation through LDLR/STAT-3/ROR-γt pathway
- Pentraxin 3 in Myocarditis: Proof-of-Principle Assessment as a Diagnostic and Prognostic Biomarker
- Perivascular Basal Echogenicity in the Fetal Heart: An Unconventional Marker of Maternal Autoimmune Antibodies
- Potential clinical implications of molecular mimicry-induced autoimmunity
- Profibrotic VEGFR3-Dependent Lymphatic Vessel Growth in Autoimmune Valvular Carditis
- Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4(+) T-cell differentiation
- Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4<sup>+</sup> T-cell differentiation
- Radiotracers for Imaging of Inflammatory Biomarkers TSPO and COX-2 in the Brain and in the Periphery
- Rechallenge With Switching Immune Checkpoint Inhibitors Following Autoimmune Myocarditis in a Patient With Lynch Syndrome
- Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases
- Rheumatic adverse events due to immune checkpoint inhibitors
- Rho kinase inhibitor Y-27632 downregulates IL-1beta expression in mice with experimental autoimmune myocarditis
- RhoA/ROCK Pathway Is Upregulated in Experimental Autoimmune Myocarditis and Is Inhibited by Simvastatin at the Stage of Myosin Light Chain Phosphorylation
- Role of CCRL2 in the Pathogenesis of Experimental Autoimmune Myocarditis via P21-Activated Kinase 1/NOD-Like Receptor Protein 3 Pathway
- Sacubitril/Valsartan inhibits M1 type macrophages polarization in acute myocarditis by targeting C-type natriuretic peptide
- SARS-CoV-2 and Its Bacterial Co- or Super-Infections Synergize to Trigger COVID-19 Autoimmune Cardiopathies
- SARS-CoV-2-induced non-bacterial endomyocarditis with the development of acquired heart defects
- Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies
- Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report
- Sex differences in coronavirus disease 2019 myocarditis
- Sex differences in mitochondrial gene expression during viral myocarditis
- Single cell RNA sequencing sheds light on infiltrating T cells in idiopathic inflammatory myopathies
- Spontaneous Recovery of Isolated Advanced Heart Block in Patient with Celiac Disease by Starting a Strict Gluten Free Diet: A Case Report and Review of the Literature
- Subcutaneous anakinra in the management of refractory MIS-C in France
- Systematic Aetiological Assessment of Myocarditis: A Prospective Cohort Study
- T-Cell Receptor Sequences Identify Combined Coxsackievirus-<em>Streptococci</em> Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus-<em>Clostridia</em> Infections for Type 1 Diabetes
- T-Cell Receptor Sequences Identify Combined Coxsackievirus-Streptococci Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus-Clostridia Infections for Type 1 Diabetes
- Thalidomide and a Dipeptidyl Peptidase 4 Inhibitor in a Rat Model of Experimental Autoimmune Myocarditis
- The Diagnostic Dilemma of "The Great Imitator": Heart and Cerebral Involvement of Lupus Manifesting as Bilateral Upper and Lower Extremity Weakness
- The knowns and unknowns of cardiac autoimmunity in viral myocarditis
- The Significance of Parametric Mapping in Advanced Cardiac Imaging
- Thymoma-Associated Myasthenia Gravis With Myocarditis
- Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
- TNF-alpha protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells
- TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells
- Uneventful COVID-19 Infection and Vaccination in a Cohort of Patients with Prior Myocarditis
- Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicities
- Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis
- Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis